View
459
Download
21
Category
Preview:
DESCRIPTION
hepatich encephalopathy in children & its management with referrence from standard text books
Citation preview
Hepatic Encephalopathy Hepatic Encephalopathy
Dr Bikash Ranjan PraharajPost Graduate, Dept of Pediatrics
MKCG Medical College, Berhampur
• Definition• Etiology & classification• Pathogenesis• Precipitating factors• Clinical manifestation• Management • Outcome
Definition
Hepatic encephalopathy (HE) is a complex metabolic mental state disorder with a spectrum of potentially reversible neuropsychiatric abnormalities seen in patients with severe acute or chronic liver dysfunction after exclusion of other brain diseases
Characterized by
Disturbances in consciousness & behaviour
Personality changes
Fluctuating neurologic signs, asterixis or
flapping tremor
Distinctive EEG changes
Epidemiology Exact data regarding incidence and prevalence is lacking 60-70% of patients with liver cirrhosis, while clinically unremarkable have pathologic changes on EEG and psychometric tests.(MHE) Prevalence of minimal HE is about 53% in patients with extra hepatic portal vein obstruction Approximately 50% of patients with liver cirrhosis develop HE after surgical portosystemic bypass procedures
Type Description Subcategory Subdivision
A
Encephalopathy associated with acute liver failure, typically associated with cerebral edema
_____ ______
B
Encephalopathy with Porto-systemic bypass and nointrinsic hepatocellular disease
_____ ______
C
Encephalopathy associated with cirrhosis or portalhypertension ⁄ Porto-systemic shunts
Episodic
Persistent
Minimal
•Percipated •Spontaneous •Recurrent •Mild •Severe•Treatment dependent
Classification
Pathogenesis Theories
– Ammonia hypothesis– False neurotransmitters & AA imbalance– Increase permeability of BBB– GABA hypothesis– Others
Alanine Transaminase (ALT)
Aspartate Transaminase(AST) The Urea Cycle
Neurotoxic Action of Ammonia• Readily crosses blood-brain barrier
• Ammonia reacts with α-ketoglutatrate to produce glutamate and glutamine
• Consumption of α-ketoglutatrate, NADH and ATP, inhibition of pyruvate decarboxylase decrease TCA cycle activity which is vital for brain metabolism
• Increased glutamine formation depletes glutamate stores which are needed by neural tissue l/t Irrepairable cell damage and neural cell death ensue.
• Directly depress the cerebral blood flow & glucose metabolism
• Direct toxic effect on the neuronal membrane
False neurotransmitters & Aminoacid imbalance
• BCAA/AAA (N= 3-3.5, In hepatic coma=0.6-1.2)
• BCAA : hyperinsulinemia increased uptake & utilization by muscle & adipocytes
• AAA :- insulin/glucagon --> catabolism of liver
proteins & muscle --> AAA - Decrease hepatic deamination- Decrease gluconeogenesis
Which ultimately l/t
Increase FNTsDecrease normal neurotransmittersIncrease inhibitory neurotransmitters
False Neurotransmitter Hypothesis
AAA are precursors to neurotransmitters and elevated levels result in shunting to secondary pathways
Increase Permeability of Blood-Brain Barrier
• Astrocyte (glial cell) volume is controlled by intracellular organic osmolyte which is glutamine
• Increase glutamine levels in the brain result in increase volume of fluid within astrocytes resulting in cerebral edema (enlarged glial cells)
• Neurological impairment
“Alzheimer type II astrocytosis”– Pale, enlarged nuclei – characterisic of HE
• Major inhibitory neurotransmitter.• Evidence: increased GABAergic tone &
Flumazenil improves clinical outcome• Cause- Decrease hepatic metabolism- Increase gut wall permeability
GABA hypothesis
Some other theories
• Dysregulation of serotonergic system (inversion of sleep rhythm)
• Depletion of zinc & accumulation of Mn in globus pallidus.
• Action of cytokines and bacterial LPS on astrocytes which are formed d/t inflmm. elsewhere in the body.
• Neuronal NO synthase may increase c/t the altered cerebral perfusion.
Other neurotoxins
• Mercaptans: Inhibit Na+-K+ ATPase• Short & medium chain fatty acids:
inhibit Na+-K+ ATPase & Urea synthase• Phenol: a neurotoxin
Precipitating factors
CLINICAL MANIFESTATIONS
• Variable & fluctuating• Mild disturbance of consciousness &
altered behavior to deep coma• Psychiatric changes of varying degrees• F/o liver cell failure like flapping tremor
& fetor hepaticus
In MHE : • children have normal abilities of
memory, language, construction & pure motor skills.
• have normal standard mental status testing & abnormal psychometric testing.
Mild to moderate HE:• Decreased short term memory or
forgetfulness• Loss of concentration & irritability• Asterixis, hyperventilation &
hypothermia• Relative bradycardia (if ass. with increase
ICP)
Clinical grading
• West Haven classification system• Prognostic significance• Better in grade I & worse in grade IV
Minimal encephalopathy
• Defined as encephalopathy that does not lead to clinically overt cognitive dysfunction but can be demonstrated with neuropsychological studies.
• May account for 60% of patients with portosystemic shunts.
Clinical Manifestations & Diagnosis :MHE • Clinically normal• No mental deficit • Normal verbal ability • Deficit in attention ,visual perception, memory function, and learning • Impaired daily activities / driving• Only sophisticated tests such as EEG,CFF,ICT,NCT,DST, RBANS & PSE Syndrome test.• Neuroimaging : SPECT ,MRI,MRS.DWI
11
2233
44
55
66
77
88
99
1010
1111
12121313
1414
1515 16161717
18181919 2020
21212222
2323
2424
2525
BeginBegin
EndEnd
Time to complete____________________Time to complete____________________
Number Connection Test (NCT)Number Connection Test (NCT)
SAMPLE HANDWRITINGSAMPLE HANDWRITING
Draw a starDraw a star
Manifestations & Diagnosis :MHE
Diagnosis of HE
• No single laboratory test is sufficient to establish the diagnosis– No Gold Standard
• Dx is mainly clinical on basis of history, clinical exam (includ mental status) & raised blood ammonia level
Diagnostic Criteria• Asterixis (“flapping tremor”)• Hx liver disease• Impaired performance on neuropsychological tests
– Visual, sensory, brainstem auditory evoked potentials• Sleep disturbances• Fetor Hepaticus• EEG• PET scan
– Changes of neurotransmission, astrocyte function• Elevated serum NH3
– Stored blood contains ~30ug/L ammonia– Elevated levels seen in 90% pts with HE– Not needed for diagnosis
Investigations
Confirmation of liver disease/portosystemic shunt
1. LFT: increase in the following - Sr bilirubin/AST/ALT/ALP/GGT - PT(INR) > 1.5 with encephalopathy or >2
without encephalopathy - Sr protein, A:G ratio2. Sr ammonia level is increased in most cases3. USG
Detection of causative factors• Viral serologic markers: HBs Ag, HBe Ag, anti-HBc,
HBV DNA increased in Hepatitis• TORCH screening• Autoimmune ab: ANA, ASMA, LKM1• Sr Cu, ceruloplasmin, urinary Cu : wilson’s disease• Urine for metabolic disorders• Sweat chloride & cystic fibrosis mutation studies• Alfa 1 antitrypsin levels : Alfa 1 antitrypsin def • Alfa feto protein : tyrosinemia type 1• Sr lactate & pyruvate : GSD & resp chain defects• Liver biopsy: cirrhosis
R/o other diseases with similar presentation
• CT Scan: to r/o cerebral hemorrhage• EEG: r/o seizure disorder• CSF study: meningitis or encephalitis• Blood tests: metabolic causes of
encephalopathy including hypoglycemia & uremia
• Serum urea, Cr & electrolytes: renal failure
Detection of complications• ABG- hypoxia is common• CBC: to r/o infection• Hb,PCV,CPS• PT, aPTT• Pt count decreased in advanced cases &
coagulopathy• Blood glucose: hypoglycemia• Sr ammonia• RFT
Differential Diagnosis
Metabolic encephalopathies- Diabetes (hypoglycemia, ketoacidosis)- Hypoxia- Carbon dioxide narcosis
Toxic encephalopathies- Alcohol (acute alcohol intoxication, delirium tremens, Wernicke-Korsakoff syndrome)- Drugs
Intracranial events- Intracerebral bleeding or infarction-Tumor- Infections (abscess, meningitis)- Encephalitis
Psychiatric diseases
Treatment of Hepatic Encephalopathy
• Various measures in current treatment of HE– Strategies to lower ammonia production/absorption
• Nutritional management– Protein restriction– BCAA supplementation
• Medical management– Medications to counteract ammonia’s effect on brain cell
function• Lactulose• Antibiotics
– Devices to compensate for liver dysfunction– Liver transplantation
ProposedComplexFeedback Mechanisms In TreatmentOf HE
Diet
• Decreased protein intake with high carbohydrates
• Calorie in the form of 10%D infusion• Protein restricted to 0.5-1 g/kg/day• Veg protein preferred as they are less
amminogenic , contain less amount of methionine & AAA and more fibres
• Dietary supplementation of BAA• 50% of non-protein calories should come from
MCT
Lactulose/lactitol• Non absorbable synthetic diasachharide• Degraded by colonic bacteria to form lactic acid & acetic
acid
• Fecal acidity increase l/t decrease absorption of NH3• Favours growth of lactose fermenting bacteria &
diminished growth of ammo producing bacteria like bacteroides
• Detoxify short chain FAs produced in presence of blood & proteins
Dose: 1-2 ml/kg per orally or as enema in higher dosesN:B:- Alternatively, phosphate enema can be used
Actions Of Lactulose
Bowel sterilization
• Neomycin : orally through NGT dose: 50-100mg/kg
• Ampicillin• Rifaximin • metronidazole
Other measures
• NGT aspiration• High colonic wash• Zn • L-Ornithine-L-Aspartate : oral/iv• Sodium Benzoate: 5g PO BD• H.Pylori eradication
Supportive care• Fluid & electrolyte balance: - Should contain 1meq/kg/d of glucose- Met acidosis: NaHco3- Hypokalemia: pot. Chloride• Early identification & T/t of GI bleeding,
septicemia & hypoxia• Avoidance of ppt factors: drugs/paracentesis• Drugs: To improve sensorium e.g Flumazenil, l-
dopa, bromocriptine
T/t in Resistant cases
• Plasmapheresis/hemodialysis• exchange transfusion• Surgical shunt occlusion • Temporary hepatic support:- ELAD (Extracorporeal Liver Assist Devices)- MARS (Molecular Adsorbent Recirculating
System)• Liver transplantation
T/t of complications
1. CNS complications:• Cerebral edema:- Elevation of bed by 30 “,mannitol,
hyperventilation & fluid restriction- Hypothermia & phenobarbitone• Seizures: phenytoin & gabapentin• Cerebral hypoxia: O2, N-acetylcysteine2. Hypotension: colloids/albumin infusion3. Bleeding: Inj Vit-k/ FFP/ Inj Ranitidine
4. Respiratory failure: - In Stage III & IV- Endotracheal Intubation 5. Renal Failure: - Furosemide in a dose of 1-2 mg/kg in early
stages if CVP > 8-10 cm of H2O- Hemodialysis in established cases- Urine output should be maintained- Dopamine: Improve renal perfusion6. Ascites: 5% albumin, bile acid binders
Monitoring Protocol
Daily Once in 3 days Weekly
•Blood glucose (2 hrly)•Sr electrolytes: Na, K, HCO3-•Hb, PCV, CPS
-Renal function tests-PT-NEC
-Sr amino acids-EEG
Minimal HE
1.No established indication for treatment 2.Consider changes in daily activities (avoid
driving)3.In selected patients • Lactulose /lactitol• Dietary intervention vegetable based diet• Probiotics
1.Control of precipitating factors2.Nutritional support 3.Adequate protein intake with dairy and
vegetable based diets 4.Vitamins 5.Zinc supplementation 6.Lactulose /lactitol as needed 7. OLT evaluation
Prophylaxis Of New Episodes
Course And Prognosis
•Develops rapidly few hours – 1-2 days•Mortality in grade IV is 80% •Death usually due to brain herniation / edema ICH•Type C develops slowly – undulating course / recurrence •Neuropsychiatric manifestations are reversible•Can lead to permanent damage with dementia, extra pyramidal signs, cerebellar degeneration,myelopathy with spastic paraplegia, peripheral polyneuropthy•Liver TX can reverse all changes
Prognostic indicatorsFEATURES GOOD PROGNOSIS BAD PROGNOSIS
AGE CHILDREN ADOLESCENTS
ETIOLOGY PCM POISONING, HEP A HEP C
DURATION OF ENCEPHALOPATHY < 7 DAYS > 7 DAYS
COMA GRADE I & II III & IV
LIVER SIZE ENLARGED SHRINKING/NON PALPABLE
BLEEDING TENDENCY ABSENT PRESENT
FLUID RETENTION ---- +++
SR ALBUMIN N
PT N PROLONGED
LIVER ENZYMES: AST/ALT N
AFP
ASS. COMPLICATIONS ABSENT PRESENT
IMPROVEMENT OF SENSORIUM WITH T/t RAPID NO IMPROVEMENT AFTER
48 HRS OF T/t
Take home points• Ammonia is the main culprit• Dx mainly by clinical exclusion• Bad prognostic indicators: - Liver span - Bilirubin level - Liver enzyme levels - Prothrombin time• T/t of precipitating causes & supportive care is
the mainstay of t/t• Prognosis bad in type A & better in other types
ThanksThanks
Recommended